Zobrazeno 1 - 10
of 41
pro vyhledávání: '"James M. Kirshenbaum"'
Autor:
John H. Bertot, Dan Marcusa, Parth Patel, David Gross, James M. Kirshenbaum, Marc Steven Sabatine, Ajar Kochar
Publikováno v:
Journal of the American College of Cardiology. 81:2558
Autor:
S. E. Culbreth, Edward W. Boyer, Bryan D. Hayes, Enrico G. Ferro, James M. Kirshenbaum, Peter R. Chai, Timothy B. Erickson
Publikováno v:
Journal of Medical Toxicology
Introduction Recent attention on the possible use of hydroxychloroquine and chloroquine to treat COVID-19 disease has potentially triggered a number of overdoses from hydroxychloroquine. Toxicity from hydroxychloroquine manifests with cardiac conduct
Autor:
Calum A. MacRae, Stephanie Sibicky, David P. Faxon, James M. Kirshenbaum, Lina Matta, Christine M. Gillis, Jillian Dempsey, William W. Churchill
Publikováno v:
American Journal of Health-System Pharmacy. 75:S63-S71
Purpose The utility of a transitions-of-care (TOC) pharmacist intervention focused on improving the quality and safety of the medication process for high-risk cardiovascular patients was evaluated. Methods A quality-improvement initiative was develop
Autor:
James M. Kirshenbaum, S. E. Culbreth, Enrico G. Ferro, Edward W. Boyer, Peter R. Chai, Timothy B. Erickson, Bryan D. Hayes
Publikováno v:
Journal of Medical Toxicology
J Med Toxicol
J Med Toxicol
Autor:
Marcelo F. Di Carli, Stephen Horgan, Alfonso H. Waller, James M. Kirshenbaum, Sharmila Dorbala, Vikas Veeranna
Publikováno v:
Journal of Nuclear Cardiology. 23:316-320
Autor:
William J. Hucker, James M. Kirshenbaum, Michael L. Steigner, Gayle L. Winters, Yiannis S. Chatzizisis
Publikováno v:
Circulation. 130:854-862
Autor:
Marcelo F. Di Carli, Raymond Y. Kwong, Edward Hulten, Sanjay Divakaran, Jon Hainer, Ron Blankstein, Mitalee P. Christman, James M. Kirshenbaum, Sharmila Dorbala, Daniel E. Forman, Márcio Sommer Bittencourt, Hicham Skali
Publikováno v:
Am J Cardiol
While exercise treadmill test (ETT) is a useful initial test for patients with suspected cardiovascular disease, there is concern regarding the use of downstream imaging tests especially in the setting of equivocal or positive ETTs. Patients with no
Autor:
James M. Kirshenbaum, Rodrigo Vugman Wainstein, Michael K.Y. Lee, Dominik Behrendt, Lucila Ohno-Machado, Robert N. Piana, Frederic S. Resnic, Marco Vugman Wainstein, Jeffrey J. Popma, Campbell Rogers
Publikováno v:
American Heart Journal. 145:42-46
No-reflow occurring during percutaneous coronary intervention (PCI) has been associated with poor inhospital outcomes. The objectives of this analysis were to evaluate the occurrence of no-reflow as an independent predictor of adverse events and to d
Publikováno v:
New England Journal of Medicine. 376:e23
Publikováno v:
Journal of the American College of Cardiology. 69:2226